» Articles » PMID: 1846840

Angiotensin-(1-7). A Member of Circulating Angiotensin Peptides

Overview
Journal Hypertension
Date 1991 Feb 1
PMID 1846840
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We measured the concentrations of three principal products of the renin-angiotensin system and seven of their metabolites in the plasma of anesthetized normal dogs and in dogs 24 hours after bilateral nephrectomy. The levels of the angiotensin peptides were measured by high-performance liquid chromatography combined with radioimmunoassay using three specific antibodies that recognized different epitotes in the sequences of angiotensin I, angiotensin II, and angiotensin-(1-7). The analysis revealed that angiotensin-(1-7) is present in the plasma of intact (4.9 +/- 2.2 fmol/ml) and nephrectomized (0.5 +/- 0.5 fmol/ml) dogs. An intravenous injection of purified hog renin (0.01 Goldblatt unit/kg) increased plasma levels of angiotensin I, angiotensin II, and angiotensin-(1-7) both before and after nephrectomy. These changes were associated with parallel increases in the concentrations of fragments of the three parent peptides. Administration of MK-422 led to the disappearance of circulating angiotensin II and its fragments both before and after a second injection of the same dose of renin. In contrast, MK-422 augmented the plasma levels of both angiotensin I and angiotensin-(1-7). The concentrations of these two peptides, but not the blood pressure, were again augmented by a second injection of renin given after blockade of converting enzyme. These effects were observed both before and after bilateral nephrectomy. These findings show that angiotensin-(1-7) circulates in the blood of normal and nephrectomized dogs. In addition, we found that angiotensin-(1-7) is generated in the blood from the cleavage of angiotensin I through a pathway independent of converting enzyme (EC 3.4.15.1).

Citing Articles

Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.

Molaei A, Molaei E, Wallace Hayes A, Karimi G Cell Cycle. 2023; 22(13):1654-1674.

PMID: 37365840 PMC: 10361149. DOI: 10.1080/15384101.2023.2228089.


Novel roles of the renal angiotensin-converting enzyme.

Giani J, Veiras L, Shen J, Bernstein E, Cao D, Okwan-Duodu D Mol Cell Endocrinol. 2021; 529:111257.

PMID: 33781839 PMC: 8127398. DOI: 10.1016/j.mce.2021.111257.


Blockade of Endogenous Angiotensin-(1-7) in Hypothalamic Paraventricular Nucleus Attenuates High Salt-Induced Sympathoexcitation and Hypertension.

Yu X, Miao Y, Li H, Su Q, Liu K, Fu L Neurosci Bull. 2018; 35(1):47-56.

PMID: 30328008 PMC: 6357275. DOI: 10.1007/s12264-018-0297-4.


Angiotensin-(1-7) contributes to insulin-sensitizing effects of angiotensin-converting enzyme inhibition in obese mice.

Loloi J, Miller A, Bingaman S, Silberman Y, Arnold A Am J Physiol Endocrinol Metab. 2018; 315(6):E1204-E1211.

PMID: 30300010 PMC: 6336955. DOI: 10.1152/ajpendo.00281.2018.


Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance.

Lee R, Dickhout J, Sandow S Hypertens Res. 2016; 40(4):311-323.

PMID: 27784889 DOI: 10.1038/hr.2016.145.